Cargando…
Screening Malaria-box compounds to identify potential inhibitors against SARS-CoV-2 M(pro), using molecular docking and dynamics simulation studies
Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2) Main protease (M(pro)) is one of the vital drug targets amongst all the coronaviruses, as the protein is indispensable for virus replication. The study aimed to identify promising lead molecules against M(pro) enzyme through virtual screen...
Autores principales: | Ahamad, Shahzaib, Kanipakam, Hema, Birla, Shweta, Ali, Md Shaukat, Gupta, Dinesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584923/ https://www.ncbi.nlm.nih.gov/pubmed/33131721 http://dx.doi.org/10.1016/j.ejphar.2020.173664 |
Ejemplares similares
-
Identification
of Novel Tau-Tubulin Kinase 2 Inhibitors
Using Computational Approaches
por: Ahamad, Shahzaib, et al.
Publicado: (2023) -
Unravelling high-affinity binding compounds towards transmembrane protease serine 2 enzyme in treating SARS-CoV-2 infection using molecular modelling and docking studies
por: M, Pooja, et al.
Publicado: (2021) -
Atomic Resolution Homology Models and Molecular Dynamics
Simulations of Plasmodium falciparum Tubulins
por: Hema, Kanipakam, et al.
Publicado: (2021) -
A molecular journey to check the conformational dynamics of tau tubulin kinase 2 mutations associated with Alzheimer's disease
por: Ahamad, Shahzaib, et al.
Publicado: (2021) -
Insights into the structure and dynamics of SARS-CoV-2 spike glycoprotein double mutant L452R-E484Q
por: Ahamad, Shahzaib, et al.
Publicado: (2022)